keyword
https://read.qxmd.com/read/38691891/targeting-the-cysteine-biosynthesis-pathway-in-microorganisms-mechanism-structure-and-drug-discovery
#1
REVIEW
Ying Tao, Dandan Zheng, Wei Zou, Ting Guo, Guojian Liao, Wei Zhou
Owing to the global health crisis of resistant pathogenic infections, researchers are emphasizing the importance of novel prevention and control strategies. Existing antimicrobial drugs predominantly target a few pathways, and their widespread use has pervasively increased drug resistance. Therefore, it is imperative to develop new antimicrobial drugs with novel targets and chemical structures. The de novo cysteine biosynthesis pathway, one of the microbial metabolic pathways, plays a crucial role in pathogenicity and drug resistance...
April 28, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38691889/discovery-of-potent-and-novel-dual-nampt-brd4-inhibitors-for-efficient-treatment-of-hepatocellular-carcinoma
#2
JOURNAL ARTICLE
Chunjia Yin, Shuting Jia, Xiaojuan Yang, Liqiang Wu
The NAPRT-induced increase in NAD+ levels was proposed as a mechanism contributing to hepatocellular carcinoma (HCC) resistance to NAMPT inhibitors. Thus, concurrently targeting NAMPT and NAPRT could be considered to overcome drug resistance. A BRD4 inhibitor downregulates the expression of NAPRT in HCC, and the combination of NAMPT inhibitors with BRD4 inhibitors simultaneously blocks NAD+ generation via salvage and the PH synthesis pathway. Moreover, the combination of the two agents significantly downregulated the expression of tumor-promoting genes and strongly promoted apoptosis...
April 26, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38691846/exploiting-metabolic-defects-in-glioma-with-nanoparticle-encapsulated-nampt-inhibitors
#3
JOURNAL ARTICLE
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee-Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
The treatment of primary central nervous system (CNS) tumors is challenging due to the blood-brain barrier and complex mutational profiles, which is associated with low survival rates. However, recent studies have identified common mutations in gliomas (IDH-WT and mutant, WHO grades II-IV; with grade IV tumors referred to as glioblastomas; GBMs). These mutations drive epigenetic changes, leading to promoter methylation at the NAPRT gene locus, which encodes an enzyme involved in generating NAD+. Importantly, NAPRT-silencing introduces a therapeutic vulnerability to inhibitors targeting another NAD+ biogenesis enzyme, NAMPT, rationalizing a treatment for these malignancies...
May 1, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38691831/tongfu-lifei-decoction-attenuated-sepsis-related-intestinal-mucosal-injury-through-regulating-th17-treg-balance-and-modulating-gut-microbiota
#4
JOURNAL ARTICLE
Huizhen Chen, Zhenfei Yu, Zeming Qi, Xiaozhe Huang, Jianting Gao
Intestinal damage and secondary bacterial translocation are caused by the inflammatory response induced by sepsis. Tongfu Lifei (TLF) decoction has a protective effect on sepsis-related gastrointestinal function injury. However, the relation between gut microbiota, immune barrier, and sepsis under the treatment of TLF have not been well clarified yet. Here, rats were subjected to cecal ligation and puncture (CLP) to create a sepsis model. Subsequently, the TLF decoction was given to CLP rats by gavage, fecal microbiota transplantation (FMT), and antibiotic were used as positive control...
May 2024: Journal of Interferon & Cytokine Research
https://read.qxmd.com/read/38691665/edaravone-oral-suspension-a-neuroprotective-agent-to-treat-amyotrophic-lateral-sclerosis
#5
REVIEW
Priya Singh, Paul Belliveau, Jennifer Towle, Andrea Elena Neculau, Lorena Dima
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is characterized by loss of motor neurons due to degeneration of nerve cells within the brain and spinal cord. Early symptoms include limb weakness, twitching or muscle cramping, and slurred speech. As the disease progresses, difficulty breathing, swallowing, and paralysis can lead to death. Currently, there are no medications that cure ALS, and guidelines recommend treatments focused on symptom management. Intravenous (IV) edaravone was approved by the US Food and Drug Administration (FDA) in 2017 as a treatment to slow the progression of ALS...
May 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38691644/resmetirom-rezdiffra-for-metabolic-dysfunction-associated-steatohepatitis
#6
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
April 29, 2024: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/38691441/pre-treatment-bone-mineral-density-bmd-and-the-benefit-of-pharmacologic-treatment-on-fracture-risk-and-bmd-change-analysis-from-the-fnih-asbmr-sabre-project
#7
JOURNAL ARTICLE
Marian Schini, Tatiane Vilaca, Li-Yung Lui, Susan K Ewing, Austin Thompson, Eric Vittinghoff, Douglas C Bauer, Mary L Bouxsein, Dennis M Black, Richard Eastell
Some osteoporosis drug trials have suggested that treatment is more effective in those with low bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA). This study used data from a large set of randomised controlled trials (RCTs) to determine whether the anti-fracture efficacy of treatments differs according to baseline BMD. We used individual patient data from 25 RCTs (103 086 subjects) of osteoporosis medications collected as part of the FNIH-ASBMR SABRE project. Participants were stratified into femoral neck (FN) BMD T-score subgroups (≤ -2...
May 1, 2024: Journal of Bone and Mineral Research
https://read.qxmd.com/read/38691320/sex-differences-in-adverse-effects-of-antiseizure-medications-in-adults-with-epilepsy-a-systematic-review
#8
Loretta Giuliano, Vania Durante, Giulia Battaglia, Sara Gasparini, Elena Zambrelli, Caterina Ermio, Angela La Neve, Barbara Mostacci
BACKGROUND: Sex differences in epilepsy have been described in prevalence, seizure propensity and response to treatment. Therefore, taking into account sex-based differences in epilepsy is important for both diagnostic purposes and therapeutic considerations. However, little is known about sex differences in adverse effects of antiseizure medications (ASMs). OBJECTIVES: We performed a systematic review searching for sex differences in adverse effects of ASMs in adult persons with epilepsy (PWE) as part of a wider project aimed to assess sex-based differences in efficacy and adverse effects of ASMs in PWE...
April 30, 2024: CNS Drugs
https://read.qxmd.com/read/38691241/identification-of-potential-key-lipid-metabolism-related-genes-involved-in-tubular-injury-in-diabetic-kidney-disease-by-bioinformatics-analysis
#9
JOURNAL ARTICLE
Yuanshuo Fan, Juan He, Lixin Shi, Miao Zhang, Ye Chen, Lifen Xu, Na Han, Yuecheng Jiang
AIMS: Accumulating evidences indicate that abnormalities in tubular lipid metabolism play a crucial role in the development of diabetic kidney disease (DKD). We aim to identify novel lipid metabolism-related genes associated with tubular injury in DKD by utilizing bioinformatics approaches. METHODS: Differentially expressed genes (DEGs) between control and DKD tubular tissue samples were screened from the Gene Expression Omnibus (GEO) database, and then were intersected with lipid metabolism-related genes...
May 1, 2024: Acta Diabetologica
https://read.qxmd.com/read/38690893/bactericidal-and-sterilizing-activity-of-sudapyridine-clofazimine-tb47-combined-with-linezolid-or-pyrazinamide-in-a-murine-model-of-tuberculosis
#10
JOURNAL ARTICLE
Wei Yu, Yanan Ju, Xingli Han, Xirong Tian, Jie Ding, Shuai Wang, H M Adnan Hameed, Yamin Gao, Lei Li, Yongguo Li, Nanshan Zhong, Tianyu Zhang
As an obligate aerobe, Mycobacterium tuberculosis relies on its branched electron transport chain (ETC) for energy production through oxidative phosphorylation. Regimens targeting ETC exhibit promising potential to enhance bactericidal activity against M. tuberculosis and hold the prospect of shortening treatment duration. Our previous research demonstrated that the bacteriostatic drug candidate TB47 (T) inhibited the growth of M. tuberculosis by targeting the cytochrome bc1 complex and exhibited synergistic activity with clofazimine (C)...
May 1, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38690743/rapid-and-definitive-identification-of-cyclic-peptide-soft-spots-by-isotope-labeled-reductive-dimethylation-and-mass-spectrometry-fragmentation
#11
JOURNAL ARTICLE
Yu Feng, Athanasia Qirjollari, Maria V Fawaz, Mark T Cancilla, Raymond J Gonzalez, Kara Pearson
Cyclic peptides are an emerging therapeutic modality over the past few decades. To identify drug candidates with sufficient proteolytic stability for oral administration, it is critical to pinpoint the amide bond hydrolysis sites, or soft spots, to better understand their metabolism and provide guidance on further structure optimization. However, the unambiguous characterization of cyclic peptide soft spots remains a significant challenge during early stage discovery studies, as amide bond hydrolysis forms a linearized isobaric sequence with the addition of a water molecule, regardless of the amide hydrolysis location...
May 1, 2024: Analytical Chemistry
https://read.qxmd.com/read/38690363/gallein-potentiates-isoniazid-s-ability-to-suppress-mycobacterium-tuberculosis-growth
#12
JOURNAL ARTICLE
Ramesh Rijal, Richard H Gomer
Mycobacterium tuberculosis ( Mtb ), the bacterium that causes tuberculosis (TB), can be difficult to treat because of drug tolerance. Increased intracellular polyphosphate (polyP) in Mtb enhances tolerance to antibiotics, and capsular polyP in Neisseria gonorrhoeae potentiates resistance to antimicrobials. The mechanism by which bacteria utilize polyP to adapt to antimicrobial pressure is not known. In this study, we found that Mtb adapts to the TB frontline antibiotic isoniazid (INH) by enhancing the accumulation of cellular, extracellular, and cell surface polyP...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38690282/the-role-and-therapeutic-potential-of-sirts-in-sepsis
#13
REVIEW
Jiaqi You, Yilin Li, Wei Chong
Sepsis is a life-threatening organ dysfunction caused by the host's dysfunctional response to infection. Abnormal activation of the immune system and disturbance of energy metabolism play a key role in the development of sepsis. In recent years, the Sirtuins (SIRTs) family has been found to play an important role in the pathogenesis of sepsis. SIRTs, as a class of histone deacetylases (HDACs), are widely involved in cellular inflammation regulation, energy metabolism and oxidative stress. The effects of SIRTs on immune cells are mainly reflected in the regulation of inflammatory pathways...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38690209/therapeutic-and-pharmacological-prospects-of-nutmeg-seed-a-comprehensive-review-for-novel-drug-potential-insights
#14
REVIEW
Sawsan S Al-Rawi, Ahmad Hamdy Ibrahim, Heshu Jalal Ahmed, Zhikal Omar Khudhur
BACKGROUND AND OBJECTIVES: For centuries, plant seed extracts have been widely used and valued for their benefits. They have been used in food, perfumes, aromatherapy, and traditional medicine. These natural products are renowned for their therapeutic properties and are commonly used in medicinal treatments. Their significant pharmacological profiles provide an excellent hallmark for the prevention or treatment of various diseases. In this study, we comprehensively evaluated the biological and pharmacological properties of nutmeg seeds and explored their efficacy in treating various illnesses...
June 2024: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
https://read.qxmd.com/read/38689985/nonalcoholic-steatohepatitis-a-comprehensive-updated-review-of-risk-factors-symptoms-and-treatment
#15
REVIEW
Feryal Savari, Seyed Ali Mard
Non-alcoholic steatohepatitis (NASH) is a subtype of nonalcoholic fatty liver disease and a progressive and chronic liver disorder with a significant risk for the development of liver-related morbidity and mortality. The complex and multifaceted pathophysiology of NASH makes its management challenging. Early identification of symptoms and management of patients through lifestyle modification is essential to prevent the development of advanced liver disease. Despite the increasing prevalence of NASH, there is no FDA-approved treatment for this disease...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38689742/metabolic-dysfunction-associated-steatotic-liver-disease-a-silent-pandemic
#16
EDITORIAL
Arghya Samanta, Moinak Sen Sarma
The worldwide epidemiology of non-alcoholic fatty liver disease (NAFLD) is showing an upward trend, parallel to the rising trend of metabolic syndrome, owing to lifestyle changes. The pathogenesis of NAFLD has not been fully understood yet. Therefore, NAFLD has emerged as a public health concern in the field of hepatology and metabolisms worldwide. Recent changes in the nomenclature from NAFLD to metabolic dysfunction-associated steatotic liver disease have brought a positive outlook changes in the understanding of the disease process and doctor-patient communication...
April 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38689609/research-progress-of-long-non-coding-rna-in-tumor-drug-resistance-a-new-paradigm
#17
REVIEW
Jing Zhang, Le Wu, Chenchen Wang, Xin Xie, Yuying Han
In the past few decades, chemotherapy has been one of the most effective cancer treatment options. Drug resistance is currently one of the greatest obstacles to effective cancer treatment. Even though drug resistance mechanisms have been extensively investigated, they have not been fully elucidated. Recent genome-wide investigations have revealed the existence of a substantial quantity of long non-coding RNAs (lncRNAs) transcribed from the human genome, which actively participate in numerous biological processes, such as transcription, splicing, epigenetics, the cell cycle, cell differentiation, development, pluripotency, immune microenvironment...
2024: Drug Design, Development and Therapy
https://read.qxmd.com/read/38689382/comprehensive-profiling-of-endocrine-metabolism-identifies-a-novel-signature-with-robust-predictive-value-in-ovarian-cancer
#18
JOURNAL ARTICLE
Dan Yu, Yan Luo, Rong Guo, Fang Ma, Yunyun Chang, Jianhong Dang
BACKGROUND: The cell endocrine pathway is a critical physiological process composed of the endoplasmic reticulum, Golgi apparatus and associated vesicles. Loss of enzymes or proteins can cause dysfunction of endoplasmic reticulum and Golgi apparatus and affect secretion pathways leading to a variety of human diseases, including cancer. METHODS: The single-cell RNA sequencing and single nucleotide variant principal component analysis data of ovarian cancer were retrieved from The Cancer Genome Atlas and Gene Expression Omnibus (GEO) datasets...
May 2024: Journal of Gene Medicine
https://read.qxmd.com/read/38689294/%C3%A3-ngstrom-scale-gold-particles-loaded-with-alendronate-via-alpha-lipoic-acid-alleviate-bone-loss-in-osteoporotic-mice
#19
JOURNAL ARTICLE
Weihang Gao, Jiao Jiao Li, Jingyu Shi, Hongbing Lan, Yuanyuan Guo, Dehao Fu
Osteoporosis is a highly prevalent metabolic disease characterized by low systemic bone mass and deterioration of bone microarchitecture, resulting in reduced bone strength and increased fracture risk. Current treatment options for osteoporosis are limited by factors such as efficacy, cost, availability, side effects, and acceptability to patients. Gold nanoparticles show promise as an emerging osteoporosis therapy due to their osteogenic effects and ability to allow therapeutic delivery but have inherent constraints, such as low specificity and the potential for heavy metal accumulation in the body...
April 30, 2024: Journal of Nanobiotechnology
https://read.qxmd.com/read/38689161/the-use-of-microdosing-for-in-vivo-phenotyping-of-cytochrome-p450-enzymes-where-do-we-stand-a-narrative-review
#20
REVIEW
Lisa T van der Heijden, Frans L Opdam, Jos H Beijnen, Alwin D R Huitema
Cytochrome P450 (CYP) enzymes play a central role in the elimination of approximately 80% of all clinically used drugs. Differences in CYP enzyme activity between individuals can contribute to interindividual variability in exposure and, therefore, treatment outcome. In vivo CYP enzyme activity could be determined with phenotyping. Currently, (sub)therapeutic doses are used for in vivo phenotyping, which can lead to side effects. The use of microdoses (100 µg) for in vivo phenotyping for CYP enzymes could overcome the limitations associated with the use of (sub)therapeutic doses of substrates...
April 30, 2024: European Journal of Drug Metabolism and Pharmacokinetics
keyword
keyword
107758
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.